PTSD Trial, Recruiting NCT05751473 Sponsor: University of Michigan Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT05751473
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who work at an organisation that is served by a participating Employee Assistance Program (EAP)
  • People who score 33 or higher on a standardised checklist used to assess PTSD symptoms (called the PCL-5)
  • People whose psychiatric medications (if any) have remained unchanged for at least 4 weeks

For the interview/qualitative portion of the study only:

  • People already enrolled in the main trial who either did or did not respond to the treatment

Who may not be able to join:

  • People with severe memory or thinking difficulties that, in the investigators' judgement, would make it hard to follow the study requirements
  • People assessed as being at high risk of suicide, based on a specific screening tool used by the trial site
  • People who currently need treatment to safely stop using alcohol or other substances
  • People currently experiencing active psychosis or bipolar disorder that is not being managed, as measured by a specific assessment tool used by the trial team
  • People currently receiving a trauma-focused talking therapy, such as Prolonged Exposure or Cognitive Processing Therapy
  • People who do not speak English (confirm with trial site regarding the reason for this requirement)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rebecca Sripada, PhD, University of Michigan

Phone: 734-232-2663

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 May 2023
Est. completion
30 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Post-Traumatic Stress Disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (PCL-5) score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov